Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2007
12/27/2007WO2007148711A1 N-(3,4-disubstituted phenyl)salicylamide derivative
12/27/2007WO2007148697A1 Inhibitor of expression of nuclear transcription factor ap-1, and pharmaceutical product and product using the inhibitor
12/27/2007WO2007148676A1 Therapeutic or prophylactic agent for leukemia
12/27/2007WO2007148648A1 Therapeutic or prophylactic agent for multiple sclerosis
12/27/2007WO2007148631A1 Composition for promoting the production of equol
12/27/2007WO2007148609A1 Ex vivo/in vivo proliferation of hematopoietic stem cell or hematopoietic progenitor cell by timp-3
12/27/2007WO2007148494A1 Agent for increasing testosterone level
12/27/2007WO2007148474A1 Preparation for external application to skin containing triterpenic acid
12/27/2007WO2007148412A1 Novel fki-3389 substance and method for producing the same
12/27/2007WO2007148330A2 Adjustable orthopedic insoles
12/27/2007WO2007148307A1 Compositions and kits comprising a melatonin component and a chondroprotective component
12/27/2007WO2007148213A2 Novel polymorph of esomeprazole potassium and process for its preparation
12/27/2007WO2007148208A2 Carbonylated (aza) cyclohexanes as dopamine d3 receptor ligands
12/27/2007WO2007148185A2 Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
12/27/2007WO2007148158A1 Enantiomerically pure flavone derivatives for the treatment of poliferative disorders and processes for their preparation
12/27/2007WO2007148137A1 Novel hydrate form of moxifloxacin monohydrochloride
12/27/2007WO2007148116A2 Topical pharmaceutical formulations
12/27/2007WO2007148113A1 Metabotropic glutamate receptor modulators
12/27/2007WO2007148103A1 Crystalline duloxetine hydrochloride
12/27/2007WO2007148102A2 Crystalline duloxetine hydrochloride
12/27/2007WO2007148096A1 Crystalline duloxetine hydrochloride
12/27/2007WO2007148094A1 Cannabinoids for use in the treatment of neuropathic pain
12/27/2007WO2007148093A1 Antibacterial compositions
12/27/2007WO2007148070A1 Chemical compounds
12/27/2007WO2007148064A1 Pteridine derivatives and their use as cathespin inhibitors
12/27/2007WO2007148062A1 Therapeutic agents
12/27/2007WO2007148061A1 Therapeutic agents
12/27/2007WO2007148048A1 Compositions comprising chitin microparticles and their medical uses
12/27/2007WO2007147889A2 Preparation of telmisartan salts
12/27/2007WO2007147884A1 2-(substituted-amino)-benzothiazole sulfonamide hiv protease inhibitors
12/27/2007WO2007147883A1 Combination of a cholinesterase inhibitor and a compound with 5-ht6 receptor affinity
12/27/2007WO2007147882A2 Aqueous suspensions of tmc278
12/27/2007WO2007147880A1 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
12/27/2007WO2007147879A1 Substituted 1,3-diphenylpropane derivatives, preparations and uses thereof
12/27/2007WO2007147873A1 Oral pharmaceutical composition of a poorly water-soluble active substance
12/27/2007WO2007147861A2 Sustained release formulations of aromatase inhibitors
12/27/2007WO2007147839A1 Glycine transporter inhibiting compounds and uses in medicine
12/27/2007WO2007147836A1 Glycine transporter inhibiting compounds and uses in medicine
12/27/2007WO2007147834A1 Glycine transporter inhibiting compounds and uses in medicine
12/27/2007WO2007147831A1 Pyrrolidine derivatives having activity at the glyt1 transporter
12/27/2007WO2007147824A1 Cinnamoyl-piperazine derivatives and their use as par- i antagonists
12/27/2007WO2007147822A1 Phenylpentadienoyl derivatives and their use as par 1 antagonists
12/27/2007WO2007147819A1 3h,11h-oxazolo[3',4':1,2]pyrido[3,4-b]indole derivatives and therapeutic use thereof
12/27/2007WO2007147809A1 Use of adenosine a1 antagonist in radiocontrast media induced nephropathy
12/27/2007WO2007147794A1 Furan derivatives and their use as antiviral agents
12/27/2007WO2007147772A1 Antimalarial agent
12/27/2007WO2007147771A2 Tetralin and indane derivatives and uses thereof
12/27/2007WO2007147770A2 Substituted phenyl methanone derivatives
12/27/2007WO2007147763A1 Arylsulfonyl naphthalene derivatives and uses thereof
12/27/2007WO2007147762A1 Arylsulfonamidyl tetralin derivatives and uses thereof
12/27/2007WO2007147746A1 2-pyrazinecarboxamide derivatives
12/27/2007WO2007147713A1 Amino derivatives of b-homoandrostanes and b-heteroandrostanes
12/27/2007WO2007147659A1 Adenosine a3 receptor agonists
12/27/2007WO2007147647A1 Pyrazolopyrimidines and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same.
12/27/2007WO2007147646A1 OXO-SUBSTITUTED IMIDAZO[1,2b]PYRIDAZINES, PRODUCTION AND USE THEREOF AS DRUGS
12/27/2007WO2007147613A2 Combinations comprising staurosprorines
12/27/2007WO2007147596A1 Galenical formulations of aliskiren and hydrochlorothiazide
12/27/2007WO2007147590A2 Solution and method to reduce, treat and/or prevent oxidative stress and cell activation
12/27/2007WO2007147578A1 Quinoline derivatives, their preparation, their use, and medicaments comprising them
12/27/2007WO2007147577A1 Quinazoline derivatives, their preparation, their use as tyrosine kinase inhibitors and medicaments comprising them
12/27/2007WO2007147576A1 Cyanoquinoline derivatives, their preparation, their use, and medicaments comprising them
12/27/2007WO2007147575A2 Substituted sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprisings same, methods of preparing same and uses same
12/27/2007WO2007147574A1 Sulfonamido-macrocycles as tie2 inhibitors and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
12/27/2007WO2007147556A1 Use of substituted 2-aminotetralines for the manufacture of a medicament for the prevention, alleviation and/or treatment of various types of pain
12/27/2007WO2007147514A1 Tablets comprising candesartan cilexetil
12/27/2007WO2007147505A2 A system for controlling administration of anaesthesia
12/27/2007WO2007147491A1 Process for the production of 2- [4 - ( 3- and 2-flu0r0benzyl0xy) benzylamin0] propan amides
12/27/2007WO2007147480A2 Polymorphic forms and process
12/27/2007WO2007147478A1 3 -amino-imidazo[1, 2-a]pyridine derivatives as sglt inhibitors
12/27/2007WO2007147401A1 4-amino-3-arylamino-6-arylpyrazolo[3,4-d]pyrimidine derivatives, methods for their preparation and their use as antiviral agents
12/27/2007WO2007147372A2 Pharmaceutical composition for administration by injection
12/27/2007WO2007147371A2 Pharmaceutical composition for oral administration
12/27/2007WO2007147370A2 Pseudoceramides and pharmaceutical and/or cosmetic compositions designed for administration to the skin containing the same
12/27/2007WO2007147346A1 Quaternary ammonium salt compounds of spirocyclopiperazines, preparation methods and uses thereof
12/27/2007WO2007147336A1 Heterocyclic non-nucleoside compounds, their peparation, pharmaceutical composition and their use as antiviral agents
12/27/2007WO2007147330A1 The application of the bakuchiol compounds
12/27/2007WO2007147319A1 Yin-nourishing capsule
12/27/2007WO2007147297A1 The use of derviate of pyridone for preventing and treating radioactive injury of lungs
12/27/2007WO2007147265A1 Polynucleotides and polypeptide sequences involved in cancer
12/27/2007WO2007147255A1 Synthetic monodisperse hemozoin crystals preparation and uses thereof
12/27/2007WO2007147252A1 Ship 1 modulator prodrugs
12/27/2007WO2007147251A1 Ship 1 modulator compounds
12/27/2007WO2007147217A1 Method of treatment of glioma brain tumour
12/27/2007WO2007133588A3 Modified chalcone compounds as antimitotic agents
12/27/2007WO2007130902A3 Therapeutic cyclopentane derivatives
12/27/2007WO2007130821A3 Mglur5 modulators ii
12/27/2007WO2007130373A3 Novel triptan formulations and methods for making them
12/27/2007WO2007127844A3 Formulations containing amide derivatives of carboxylic acid nsaids for topical administration to the eye
12/27/2007WO2007127505A3 Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
12/27/2007WO2007127216A3 Osmotic drug delivery system comprising release enhancing agent
12/27/2007WO2007127175A3 Pharmaceutical compounds
12/27/2007WO2007125542A3 A process for preparation of adapalene
12/27/2007WO2007125321A3 Purine and deazapurine derivatives as pharmaceutical compounds
12/27/2007WO2007125315A3 Pharmaceutical compounds
12/27/2007WO2007124254A3 Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
12/27/2007WO2007124123A3 Method of treating inflammation
12/27/2007WO2007122635A3 Controlled release formulation comprising anti-epileptic drugs
12/27/2007WO2007120980A3 2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases
12/27/2007WO2007120972A3 Method to treat sickle cell disease
12/27/2007WO2007120589A3 Process for the preparation of caprolactam cgrp antagonist intermediate
1 ... 3440 3441 3442 3443 3444 3445 3446 3447 3448 3449 3450 3451 3452 3453 3454 3455 3456 3457 3458 3459 3460 ... 7860